The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease (Q58436305)

Expert Opinion on Therapeutic Targets

Europe PubMed Central

title

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease (English)

0 references

1 reference

Antonio Cuadrado

1

0 references

author name string

Paz Moreno-Murciano

series ordinal

2

0 references

José Pedraza-Chaverri

series ordinal

3

0 references

language of work or name

English

0 references

publication date

March 2009

0 references

published in

0 references

volume

13

0 references

issue

3

0 references

page(s)

319-329

0 references

cites work

Molecular pathophysiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Glutathione and Parkinson's disease: is this the elephant in the room?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Modifications of the iron-neuromelanin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Intraneuronal dopamine-quinone synthesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Dopamine covalently modifies and functionally inactivates parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Oxidative and antioxidative potential of brain microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

The transcription factor Nrf2 is a therapeutic target against brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Sites of alkylation of human Keap1 by natural chemoprevention agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Expression of Nrf2 in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

In vivo modulation of the Parkinsonian phenotype by Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nrf2-mediated protection against 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Pharmacological and clinical aspects of heme oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

The pathogenesis of cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Heme oxygenase expression in human central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

GDNF modulates HO-1 expression in substantia nigra postnatal cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Heme oxygenase-1 induction by dieldrin in dopaminergic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Parkinson's disease: a disorder due to nigral glutathione deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Redox regulation of neuronal survival mediated by electrophilic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Increased nuclear factor-erythroid 2 p45-related factor 2 activity protects SH-SY5Y cells against oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Protective effect of sulforaphane against dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Multitargeted cancer prevention by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Neuroprotective, anti-apoptotic effects of apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Carnosol, a component of rosemary (Rosmarinus officinalis L.) protects nigral dopaminergic neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501

Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780802716501